Ebselen, a Selenium-Containing Redox Drug, Releases Zinc from Metallothionein
- 1 July 1998
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 248 (3), 569-573
- https://doi.org/10.1006/bbrc.1998.9026
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Thiolate ligands in metallothionein confer redox activity on zinc clustersProceedings of the National Academy of Sciences, 1998
- Control of zinc transfer between thionein, metallothionein, and zinc proteinsProceedings of the National Academy of Sciences, 1998
- Ebselen in Acute Ischemic StrokeStroke, 1998
- Molecular actions of Ebselen—an antiinflammatory antioxidantGeneral Pharmacology: The Vascular System, 1995
- Ebselen, a selenoorganic compound as glutathione peroxidase mimicFree Radical Biology & Medicine, 1993
- Determination of the relative contributions of the diselenide and selenol forms of ebselen in the mechanism of its glutathione peroxidase-like activityChemico-Biological Interactions, 1992
- [6] Standard isolation procedure for metallothioneinMethods in enzymology, 1991
- A novel biologically active seleno-organic compound—1Biochemical Pharmacology, 1984
- Structure analysis and molecular model of the selenoenzyme glutathione peroxidase at 2.8 Å resolutionJournal of Molecular Biology, 1979
- Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteineBiochemistry, 1978